Tempest Therapeutics Inc

NASDAQ TPST

Data sourced from iex and EODHD
Download Data

Tempest Therapeutics Inc Income Statement 2012 - 2023

This table shows the Income Statement for Tempest Therapeutics Inc going from 2012 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31
Revenue
M 0 0 0 0 - - 0 1 0 10 - -
Cost of Revenue
M 0 2 1 1 - - 1 5 2 - - -
Gross Profit
M 0 -2 -1 -1 - - 0 -5 -2 10 - -
Operating Expenses
M 29 33 26 18 - - 46 71 70 58 - -
Selling, General, and Administrative Expenses (SG&A)
M 12 12 10 5 18 12 28 49 52 26 13 7
Research and Development (R&D) Expenses
M 17 23 17 14 28 14 18 22 18 22 16 6
Other Operating Expenses
M 0 -2 -1 -1 - - 0 0 0 10 - -
Costs and Expenses
M 28 33 26 18 - - 45 65 68 - - -
Operating Income
M -29 -35 -27 -19 -45 -27 -47 -76 -72 -48 -29 -14
Interest Expense
M 1 2 1 1 1 0 0 1 0 0 0 0
Non-operating Income/Expense
M 0 -1 -1 0 1 0 -4 -6 -1 -2 0 0
EBT
M -29 -36 -28 -19 -45 -27 -51 -82 -73 -50 -29 -14
Income Tax Provision
M - 1 1 0 0 0 0 0 0 -2 0 -
Income after Tax
M - -37 -30 -19 -44 -27 -51 -82 -73 -48 -29 -
Non-Controlling Interest
M - - 0 0 - - - - - - - -
Net Income
M - - -28 -19 -14 - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 15,416,203.00 11,548,907.00 3,790,303.00 31,210.00 100,654.00 100,654.00 100,654.00 100,654.00 100,654.00 100,654.00 100,654.00 25,822.33
EBITDA
M -29 -34 -27 -19 -45 -27 -49 -80 -72 -49 -29 -14
Depreciation and Amortization
M 0 1 0 0 1 0 2 2 1 0 0 0
EBIT
M -29 -35 -27 -19 -46 -27 -51 -82 -73 -50 -29 -14
Income from Discontinued Operations
M - - - - - - - - - - - -
Tax Rate (Effective)
% - -2.99 -4.41 0.47 0.46 0.62 -0.13 -0.24 -0.10 3.20 -0.31 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 - - - - - - -
Gross Profit Margin
% - - - - - - -167.80 -727.11 -711.91 100.00 - -
Operating Income Margin
% - - - - - - -15,788.47 -11,579.17 -25,992.42 -492.38 - -
Net Income Margin
% - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - -16,697.63 -12,223.74 -25,941.52 -504.06 - -
EBIT Ratio
% - - - - - - -17,256.95 -12,566.46 -26,405.78 -508.68 - -
EBT Ratio
% - - - - - - -17,256.95 -12,566.46 -26,405.78 -508.68 - -

StockViz Staff

September 20, 2024

Any question? Send us an email